cro.directory
← Compare landing

ProSciento vs Proxima Clinical Research

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/prosciento/proximacro

CategoryProScientoProxima Clinical Research
Listed sitecrocro
SummarySpecialized CRO focused on metabolic diseases (obesity, diabetes, MASLD/MASH, cardiovascular, chronic kidney disease) with two decades of expertise, a nationwide registry of 180,000+ participants, and full-service clinical development capabilities from Phase 1 through Phase 3.Proxima Clinical Research provides integrated regulatory, clinical, and quality solutions for life science companies, with expertise across device and therapeutic development pathways including IDE, 510(k), IND, NDA, and BLA submissions.
Services
  • Phase I Clinical Trials
  • Phase II Clinical Trials
  • Phase III Clinical Trials
  • Clinical Operations
  • Clinical Trial Services
  • US FDA Regulatory Strategy
  • Regulatory Affairs
  • Clinical Operations
  • Phase I Clinical Trials
  • Phase II Clinical Trials
  • Phase III Clinical Trials
  • Clinical Trial Services
  • Data Management & eClinical
ModalitiesData not yet provided.Data not yet provided.
Indications
  • Metabolic
  • Cardiovascular
  • Nephrology
Data not yet provided.
Locations
  • Headquarters, Chula Vista, California, United States
  • Headquarters, Houston, Texas, United States
CertificationsData not yet provided.Data not yet provided.
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.